Smits M - Search Results

1

Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.

Simnica D, Smits M, Willscher E, Fanchi LF, Kloots ISH, van Oort I, Gerritsen W, Mehra N, Binder M. Simnica D, et al. Among authors: smits m. JCO Precis Oncol. 2020 Nov;4:1374-1385. doi: 10.1200/PO.20.00209. JCO Precis Oncol. 2020. PMID: 35050788

2

Molecular biomarkers to guide precision medicine in localized prostate cancer.

Smits M, Mehra N, Sedelaar M, Gerritsen W, Schalken JA. Smits M, et al. Expert Rev Mol Diagn. 2017 Aug;17(8):791-804. doi: 10.1080/14737159.2017.1345627. Expert Rev Mol Diagn. 2017. PMID: 28635333 Review.

3

Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.

Smits M, Ekici K, Pamidimarri Naga S, van Oort IM, Sedelaar MJP, Schalken JA, Nagarajah J, Scheenen TWJ, Gerritsen WR, Fütterer JJ, Mehra N. Smits M, et al. Cancers (Basel). 2020 Dec 14;12(12):3756. doi: 10.3390/cancers12123756. Cancers (Basel). 2020. PMID: 33327413 Free PMC article.

4

⁶⁸Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients.

van Steenbergen TRF, Smits M, Scheenen TWJ, van Oort IM, Nagarajah J, Rovers MM, Mehra N, Fütterer JJ. van Steenbergen TRF, et al. Among authors: smits m. Cardiovasc Intervent Radiol. 2020 Jan;43(1):147-154. doi: 10.1007/s00270-019-02312-8. Epub 2019 Aug 23. Cardiovasc Intervent Radiol. 2020. PMID: 31444628 Free PMC article.

5

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.

van Dessel LF, van Riet J, Smits M, Zhu Y, Hamberg P, van der Heijden MS, Bergman AM, van Oort IM, de Wit R, Voest EE, Steeghs N, Yamaguchi TN, Livingstone J, Boutros PC, Martens JWM, Sleijfer S, Cuppen E, Zwart W, van de Werken HJG, Mehra N, Lolkema MP. van Dessel LF, et al. Among authors: smits m. Nat Commun. 2019 Nov 20;10(1):5251. doi: 10.1038/s41467-019-13084-7. Nat Commun. 2019. PMID: 31748536 Free PMC article.

6

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.

Slootbeek PHJ, Kloots ISH, Smits M, van Oort IM, Gerritsen WR, Schalken JA, Ligtenberg MJL, Grünberg K, Kroeze LI, Bloemendal HJ, Mehra N. Slootbeek PHJ, et al. Among authors: smits m. Br J Cancer. 2022 Apr;126(6):907-916. doi: 10.1038/s41416-021-01663-9. Epub 2021 Dec 15. Br J Cancer. 2022. PMID: 34912074 Free PMC article.

7

Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.

Slootbeek PHJ, Kloots ISH, Smits M, van Oort IM, Gerritsen WR, Schalken JA, Ligtenberg MJL, Grünberg K, Kroeze LI, Bloemendal HJ, Mehra N. Slootbeek PHJ, et al. Among authors: smits m. Br J Cancer. 2022 Apr;126(7):1108. doi: 10.1038/s41416-022-01765-y. Br J Cancer. 2022. PMID: 35210590 Free PMC article. No abstract available.

8

⁶⁸Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer.

de Jong AC, Smits M, van Riet J, Fütterer JJ, Brabander T, Hamberg P, van Oort IM, de Wit R, Lolkema MP, Mehra N, Segbers M, van der Veldt AAM. de Jong AC, et al. Among authors: smits m. J Nucl Med. 2020 Nov;61(11):1607-1614. doi: 10.2967/jnumed.119.241109. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169916 Free article.

9

Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer.

Rivello F, Matuła K, Piruska A, Smits M, Mehra N, Huck WTS. Rivello F, et al. Among authors: smits m. Sci Adv. 2020 Sep 30;6(40):eaaz3849. doi: 10.1126/sciadv.aaz3849. Print 2020 Sep. Sci Adv. 2020. PMID: 32998889 Free PMC article.

10

Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

van de Merbel AF, van der Horst G, van der Mark MH, Bots STF, van den Wollenberg DJM, de Ridder CMA, Stuurman D, Aalders T, Erkens-Schulz S, van Montfoort N, Karthaus WR, Mehra N, Smits M, Schalken JA, van Weerden WM, Hoeben RC, van der Pluijm G. van de Merbel AF, et al. Among authors: smits m. Cancer Gene Ther. 2022 Jun;29(6):793-802. doi: 10.1038/s41417-021-00360-2. Epub 2021 Jun 16. Cancer Gene Ther. 2022. PMID: 34135475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

889 results

Search Page